HBEGF: A Drug Target / Disease Biomarker (G1839)

Target Name: HBEGF

NCBI ID: G1839

HBEGF

HBEGF: A Drug Target / Disease Biomarker

Heterodimeric growth factor (HGF) is a protein that plays a crucial role in the development and maintenance of tissues, including muscles, nerves, and bones. It is a key regulator of cell proliferation and differentiation, and is involved in many different signaling pathways. Despite its importance, HGF has not yet been identified as a drug target or biomarker.

HGF is a 21-kDa protein that is expressed in a variety of tissues, including muscle, nerve, and bone. It is a key regulator of cell proliferation and differentiation, and is involved in many different signaling pathways. HGF signaling is involved in many different processes in the body, including cell growth, differentiation, and survival.

One of the most well-studied functions of HGF is its role in the development and maintenance of tissues. HGF is involved in the regulation of cell proliferation, and is essential for the growth and development of tissues. It is also involved in the regulation of cell differentiation, and is responsible for the development of specific cell types.

HGF is involved in many different signaling pathways, and is involved in the regulation of many different cellular processes. It is a positive regulator of many different signaling pathways, and is involved in the regulation of cell proliferation, differentiation, and survival.

One of the most promising applications of HGF is as a drug target. HGF has not yet been identified as a drug target, but it is a potential candidate for many different drugs. HGF signaling is involved in many different processes in the body, and targeting HGF with drugs that can inhibit its activity could be effective in treating a variety of diseases.

In addition to its potential as a drug target, HGF is also a potential biomarker. HGF is a protein that is expressed in many different tissues, and its levels can be used as a diagnostic marker for a variety of diseases. HGF has been shown to be involved in the regulation of many different cellular processes, and its levels may be affected by a variety of different factors, including diseases.

Overall, HGF is a protein that plays a crucial role in the development and maintenance of tissues, and its activity is involved in many different signaling pathways. While HGF has not yet been identified as a drug target or biomarker, its potential as a drug and its involvement in many different cellular processes make it a promising target for future research.

Protein Name: Heparin Binding EGF Like Growth Factor

Functions: Growth factor that mediates its effects via EGFR, ERBB2 and ERBB4. Required for normal cardiac valve formation and normal heart function. Promotes smooth muscle cell proliferation. May be involved in macrophage-mediated cellular proliferation. It is mitogenic for fibroblasts, but not endothelial cells. It is able to bind EGF receptor/EGFR with higher affinity than EGF itself and is a far more potent mitogen for smooth muscle cells than EGF. Also acts as a diphtheria toxin receptor

The "HBEGF Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HBEGF comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets